Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial.
By Aileen M. Grant, A. Avenell, M. Campbell, A. McDonald, G. Maclennan, G. McPherson, F. Anderson, Chris Cooper, R. Francis, C. Donaldson and 4 more. The Lancet, 2005
949 citations recorded by the source corpus.
Subfields: Epidemiology, Orthopedics and Sports Medicine, Pathology and Forensic Medicine
View Paper: https://www.semanticscholar.org/paper/ae9e36a0d62c35604def2d08f1100740fa269c36
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Orthopedics and Sports Medicine
In Pathology and Forensic Medicine
Citations in the corpus
- Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. (2006, background): “Low baseline concentrations may in part explain why 2 recent trials from the United Kingdom (UK), which were not included in our meta-analysis, did not achieve antifracture efficacy with 800 IU cholecalciferol/d (48, 49).”
- A pooled analysis of vitamin D dose requirements for fracture prevention. (2012, critical): “Its results largely account for the modest reduction in fracture risk in previous CaD meta-analyses,(2,24) but they have not been replicated in CaD trials in community-dwelling populations.(14,16,18,25) It is therefore unwise to generalize its findings to other populations.”